Cibc Bancorp Usa Inc. Avidity Biosciences, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 13,883 shares of RNA stock, worth $981,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,883Holding current value
$981,528% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
275Shares Held
127MCall Options Held
348KPut Options Held
184K-
Vanguard Group Inc Valley Forge, PA13.2MShares$935 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$764 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X010.8MShares$762 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY9.62MShares$680 Million4.2% of portfolio
-
Wellington Management Group LLP Boston, MA9.25MShares$654 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...